Bellevue Group AG - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 124 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2017$579,000
-36.6%
140,100
-2.7%
0.06%
-36.8%
Q3 2017$913,000
-19.1%
144,0000.0%0.10%
-28.6%
Q2 2017$1,129,000
+18.5%
144,0000.0%0.13%
+4.7%
Q1 2017$953,000
-11.4%
144,000
-7.1%
0.13%
-42.3%
Q4 2016$1,076,000
-25.5%
155,0000.0%0.22%
-15.7%
Q3 2016$1,445,000
+0.9%
155,0000.0%0.26%
-3.0%
Q2 2016$1,432,000
-38.0%
155,000
-41.5%
0.27%
-35.8%
Q1 2016$2,308,000265,0000.42%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders